Welcome to the June 2026 issue of ReFlections. The feature articles in this issue provide an examination of the role evolving therapies and earlier detection tools play in Alzheimer’s disease, an exploration of the influence neurodevelopmental disorders have on mortality and morbidity trends, and a closer look at the climb in the number of mental health claims among millennials.
Other highlights include:
- How an AI-powered app is enhancing care access while lowering costs for back pain treatment.
- A clinical trial on innovative technology that may enable earlier diagnosis and treatment of brain injuries in newborns.
- Underwriting questions answered for a delicate thyroid disorder case.
- Summaries of recent studies on the bearing cannabinoids have on the treatment of mental health and substance use disorders, the high prevalence of microplastics in prostate cancer tumors, a significant increase in cancer and dementia mortality among diabetics, and how respiratory viral infections can elevate long-term lung cancer risks.
- New Global Underwriting Manual guidelines for cervical screening, proteinuria, and more, and the availability of a Liver Function Test Calculator.
- An update on the Global Claims Manual survey results and a webinar to aid assessors with complex claim scenarios.
Read ReFlections, Volume 68
Explore the ReFlections Archive
